跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TNIK inhibitors
首页
药物
TNIK inhibitors
TNIK inhibitors
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Analogs for the treatment of disease
US 11530197 B2
申请人: INSILICO MEDICINE IP LTD
优先权: 2021
CN
EP
US
WO
11 件公开
EP 4298094 A4
申请人: INSILICO MEDICINE IP LTD
优先权: 2021
CN
EP
US
3 件公开
METHODS OF MANUFACTURING KINASE INHIBITORS
EP 4577524 A4
申请人: INSILICO MEDICINE IP LTD
优先权: 2022
CN
EP
WO
3 件公开
NOVEL BICYCLIC THIAZOLE COMPOUNDS
US 2013317218 A1
申请人: SAWA MASAAKI
优先权: 2012
US
3 件公开
N-(PHENYL)-5-(HETEROARYL)-1H-PYRAZOL-3-AMINE DERIVATIVES AS TNIK INHIBITORS FOR USE IN THE TREATMENT OF CANCER
EP 4477271 B1
申请人: KOREA RES INST CHEMICAL TECH
优先权: 2018
EP
2 件公开
TNIK INHIBITOR AND THE USE
US 2010137386 A1
申请人: YAMADA TESSHI
优先权: 2009
US
US 2010216795 A1
申请人: YAMADA TESSHI
优先权: 2010
US
Compounds as TNIK, IKKε and TBK1 inhibitors and pharmaceutical composition comprising same
US 9856216 B2
申请人: GREEN CROSS CORP
优先权: 2015
US
Kinase inhibitors
CN 120943822 A
申请人: YINGXI INTELLIGENT TECH INTELLECTUAL PROPERTY CO LTD
优先权: 2019
CN
Crystalline TNIK inhibitors and uses thereof
CN 121794259 A
申请人: YINGXI INTELLIGENT TECH INTELLECTUAL PROPERTY CO LTD
优先权: 2023
CN
TNIK INHIBITORS FOR THE TREATMENT OF PAIN
WO 2026067793 A1
申请人: INSILICO MEDICINE IP LTD
优先权: 2024
WO
药物
反馈